Impaired TGFβ Signaling in Plaque-Associated Microglia

Oliver Krzyzan1,2, Angela Kuhla3,4, Björn Spittau5

  • 1Institute of Anatomy, Rostock Medical Centre, Rostock University, 18057 Rostock, Germany.

Biomolecules
|February 27, 2026
PubMed

Insights

This study reveals that Alzheimer's disease (AD) in mice disrupts microglial cell shape and transforming growth factor beta (TGF-β) signaling. These changes in glial cells and TGF-β pathways may contribute to AD development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Aging and Alzheimer's disease (AD) are linked to significant alterations in glial cell structure and function.
  • Microglia, the brain's immune cells, and transforming growth factor beta (TGF-β) signaling are implicated in AD pathogenesis.

Purpose of the Study:

  • To investigate the three-dimensional morphology of microglia.
  • To examine the intracellular localization of phosphorylated SMAD proteins, key effectors of TGF-β signaling.
  • To analyze these factors in the amyloid precursor protein and presenilin-1 (APP/PS1) transgenic mouse model of AD.

Main Methods:

  • Utilized confocal microscopy for high-resolution imaging of glial cells.
  • Employed Simple Neurite Tracer software for quantitative analysis of cell morphology.
  • Performed immunofluorescence staining to detect pSMAD2 protein localization in microglia.

Main Results:

  • Observed significant alterations in the three-dimensional morphology of microglia in APP/PS1 mice compared to wild-type controls.
  • Found altered intracellular distribution of phosphorylated SMAD2 (pSMAD2) in microglia.
  • These findings suggest impaired canonical TGF-β signaling in the AD mouse model.

Conclusions:

  • The study demonstrates disturbed glial cell morphology in the APP/PS1 mouse model.
  • Dysfunctional TGF-β signaling cascade was identified in microglia within the AD model.
  • These cellular and signaling disturbances highlight a potential role in Alzheimer's disease pathogenesis.